ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 167 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,986,000 | +35.5% | 50,933 | +3.6% | 0.01% | +16.7% |
| Q1 2019 | $2,203,000 | +15.1% | 49,152 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $1,914,000 | -22.2% | 49,152 | -8.0% | 0.01% | 0.0% |
| Q3 2018 | $2,459,000 | +4.7% | 53,443 | -0.7% | 0.01% | 0.0% |
| Q2 2018 | $2,348,000 | +9.9% | 53,842 | -0.5% | 0.01% | 0.0% |
| Q1 2018 | $2,137,000 | +32.7% | 54,092 | +14.0% | 0.01% | +50.0% |
| Q4 2017 | $1,611,000 | +39.6% | 47,430 | +4.8% | 0.00% | +33.3% |
| Q3 2017 | $1,154,000 | +54.9% | 45,252 | +2.5% | 0.00% | +50.0% |
| Q2 2017 | $745,000 | – | 44,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |